Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-022234
Filing Date
2021-04-30
Accepted
2021-04-30 08:38:10
Documents
54
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A alks-pre14a_20210614.htm PRE 14A 3973445
2 GRAPHIC gfx2rfa343e5000015.jpg GRAPHIC 7044
3 GRAPHIC gfx2rfa343e5000036.jpg GRAPHIC 4186
4 GRAPHIC gfx2rfa343e5000018.jpg GRAPHIC 1147
5 GRAPHIC gfx2rfa343e5000020.jpg GRAPHIC 41470
6 GRAPHIC gfx2rfa343e5000031.jpg GRAPHIC 4032
7 GRAPHIC gfx2rfa343e5000034.jpg GRAPHIC 31655
8 GRAPHIC gfx2rfa343e5000004.jpg GRAPHIC 4902
9 GRAPHIC gfx2rfa343e5000047.jpg GRAPHIC 2078
10 GRAPHIC gfx2rfa343e5000008.jpg GRAPHIC 1114
11 GRAPHIC gfx2rfa343e5000051.jpg GRAPHIC 28891
12 GRAPHIC gfx2rfa343e5000021.jpg GRAPHIC 5935
13 GRAPHIC gfx2rfa343e5000007.jpg GRAPHIC 3217
14 GRAPHIC gfx2rfa343e5000001.jpg GRAPHIC 8078
15 GRAPHIC gfx2rfa343e5000048.jpg GRAPHIC 8613
16 GRAPHIC gfx2rfa343e5000016.jpg GRAPHIC 1172
17 GRAPHIC gfx2rfa343e5000052.jpg GRAPHIC 88040
18 GRAPHIC gfx2rfa343e5000045.jpg GRAPHIC 1788
19 GRAPHIC gfx2rfa343e5000010.jpg GRAPHIC 1087
20 GRAPHIC gfx2rfa343e5000041.jpg GRAPHIC 3951
21 GRAPHIC gfx2rfa343e5000009.jpg GRAPHIC 1092
22 GRAPHIC gfx2rfa343e5000053.jpg GRAPHIC 83277
23 GRAPHIC gfx2rfa343e5000025.jpg GRAPHIC 4621
24 GRAPHIC gfx2rfa343e5000035.jpg GRAPHIC 4689
25 GRAPHIC gfx2rfa343e5000002.jpg GRAPHIC 6545
26 GRAPHIC gfx2rfa343e5000006.jpg GRAPHIC 1919
27 GRAPHIC gfx2rfa343e5000017.jpg GRAPHIC 1128
28 GRAPHIC gfx2rfa343e5000013.jpg GRAPHIC 24906
29 GRAPHIC gfx2rfa343e5000038.jpg GRAPHIC 3901
30 GRAPHIC gfx2rfa343e5000042.jpg GRAPHIC 23501
31 GRAPHIC gfx2rfa343e5000039.jpg GRAPHIC 4325
32 GRAPHIC gfx2rfa343e5000029.jpg GRAPHIC 4349
33 GRAPHIC gfx2rfa343e5000046.jpg GRAPHIC 1735
34 GRAPHIC gfx2rfa343e5000026.jpg GRAPHIC 4056
35 GRAPHIC gfx2rfa343e5000030.jpg GRAPHIC 3896
36 GRAPHIC gfx2rfa343e5000049.jpg GRAPHIC 15141
37 GRAPHIC gfx2rfa343e5000022.jpg GRAPHIC 4880
38 GRAPHIC gfx2rfa343e5000028.jpg GRAPHIC 3694
39 GRAPHIC gfx2rfa343e5000043.jpg GRAPHIC 15439
40 GRAPHIC gfx2rfa343e5000005.jpg GRAPHIC 2818
41 GRAPHIC gfx2rfa343e5000044.jpg GRAPHIC 10846
42 GRAPHIC gfx2rfa343e5000050.jpg GRAPHIC 22455
43 GRAPHIC gfx2rfa343e5000032.jpg GRAPHIC 3749
44 GRAPHIC gfx2rfa343e5000003.jpg GRAPHIC 16382
45 GRAPHIC gfx2rfa343e5000011.jpg GRAPHIC 1034
46 GRAPHIC gfx2rfa343e5000033.jpg GRAPHIC 4619
47 GRAPHIC gfx2rfa343e5000040.jpg GRAPHIC 5600
48 GRAPHIC gfx2rfa343e5000012.jpg GRAPHIC 10714
49 GRAPHIC gfx2rfa343e5000019.jpg GRAPHIC 1084
50 GRAPHIC gfx2rfa343e5000024.jpg GRAPHIC 4344
51 GRAPHIC gfx2rfa343e5000023.jpg GRAPHIC 3726
52 GRAPHIC gfx2rfa343e5000037.jpg GRAPHIC 3873
53 GRAPHIC gfx2rfa343e5000014.jpg GRAPHIC 10173
54 GRAPHIC gfx2rfa343e5000027.jpg GRAPHIC 3847
  Complete submission text file 0001564590-21-022234.txt   4763490
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35299 | Film No.: 21873932
SIC: 2834 Pharmaceutical Preparations